glp-1 agonists and anesthesia news Are Serious Risks of Semaglutide Other Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia anesthesia glp-1 guidance news Guidelines – Stop GLP-1 Agonists 14 Days

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (736 amide) in type 2 (non-insulin-dependent) diabetic patients

This compromises your peptide and can completely invalidate your research

While IV therapy offers direct delivery, it is not a practical or sustainable daily routine for most people

PMID: 9832634 McNamee R, Braganza J.M, Hogg J, Leck I, Rose P, Cherry N.M

Given the heterogeneity in study populations and the predominance of post hoc analyses, further prospective research is essential to clarify these mechanisms and to evaluate whether personalized, sex-specific approaches to GLP-1 RA therapy could improve obesity treatment outcomes